Next Article in Journal
Truth Be Told—Perspectives on Openness
Previous Article in Journal
Hormonal Manipulation with Letrozole in the Treatment of Metastatic Malignant pecoma
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour

1
Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
2
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
3
Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(3), 521-524; https://doi.org/10.3747/co.21.1914
Submission received: 5 March 2014 / Revised: 8 April 2014 / Accepted: 3 May 2014 / Published: 1 June 2014

Abstract

Although metastases are common in patients with renal cell carcinoma (rcc), it is extremely rare for patients to present with metastatic rcc (mrcc) without evidence of a primary mass in the kidney. Two cases of mrcc with no detectable primary renal mass are reported here. Both patients had bilateral native kidneys in situ and no significant prior urologic history. The first patient presented with a hip fracture and was found to have multiple radiologic bony and lung metastases. Biopsy of a mass involving the pubic bone demonstrated clear cell mrcc. Multiple scans by computed tomography (ct) and confirmatory imaging by magnetic resonance demonstrated no renal mass. This first patient had disease stabilization for 18 months on sunitinib and was still alive at last follow-up. The second patient was diagnosed with clear-cell mrcc after thickened synovium was discovered and biopsied during a knee arthroplasty. Multiple scans by ct in this second patient demonstrated no primary renal mass. Sunitinib and radiotherapy to the knee lesion were initiated, but unfortunately, the patient deteriorated clinically and passed away from disease progression shortly after diagnosis. Because of the rare nature of these cases, a standardized course of action has not yet been established. However, we hypothesize that it is reasonable to manage metastases in these patients by following established mrcc protocols.
Keywords: metastatic renal cell carcinoma; kidney cancer; no primary tumour metastatic renal cell carcinoma; kidney cancer; no primary tumour

Share and Cite

MDPI and ACS Style

Kumar, R.M.; Aziz, T.; Jamshaid, H.; Gill, J.; Kapoor, A. Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour. Curr. Oncol. 2014, 21, 521-524. https://doi.org/10.3747/co.21.1914

AMA Style

Kumar RM, Aziz T, Jamshaid H, Gill J, Kapoor A. Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour. Current Oncology. 2014; 21(3):521-524. https://doi.org/10.3747/co.21.1914

Chicago/Turabian Style

Kumar, R.M., T. Aziz, H. Jamshaid, J. Gill, and A. Kapoor. 2014. "Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour" Current Oncology 21, no. 3: 521-524. https://doi.org/10.3747/co.21.1914

APA Style

Kumar, R. M., Aziz, T., Jamshaid, H., Gill, J., & Kapoor, A. (2014). Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour. Current Oncology, 21(3), 521-524. https://doi.org/10.3747/co.21.1914

Article Metrics

Back to TopTop